Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
06/11/2025
Nissan's Chief Financial Officer: Some measures of the plan to turn losses into profits have not been disclosed yet, and we are still working towards implementing these measures.
Latest
3 m ago
C4 Therapeutics (C4.US): The Q3 financial report for 2025 achieved revenue of $11.23 million, compared to $15.36 million in the previous period and expected revenue of $6.368 million. Earnings per share were -$0.44, compared to -$0.35 in the previous period and expected earnings of -$0.42.
3 m ago
TripAdvisor (TRIP.US): In the third quarter of 2025, the revenue reached 553 million US dollars, compared to the previous value of 532 million US dollars, and the expected value of 561.9 million US dollars; earnings per share were 0.65 US dollars, compared to the previous value of 0.50 US dollars, and the expected value of 0.47 US dollars.
3 m ago
Warner Bros. Discovery, Inc.: Expected to further achieve healthy free cash flow generation in the fourth quarter.
4 m ago
The starting price for the pre-sale of the Xiaopeng X9 super long-range is 350,000 yuan, and it will officially go on sale this month.
4 m ago
Regenxbio (RGNX.US): In the third quarter of 2025, the revenue reached 29.733 million US dollars, up from 24.197 million US dollars in the previous period, and higher than the expected value of 24.2552 million US dollars. Earnings per share were -1.20 US dollars, compared to -1.17 US dollars in the previous period, and better than the expected value of -1.33 US dollars.
See all latest